- Status:
- Red
- Decision Date:
- September 2020
Comments
RED8: NICE TA642 for treating relapsed or refractory acute myeloid leukaemia. (Decision date - September 2020)
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again
